(Total Views: 554)
Posted On: 12/29/2020 4:12:47 PM
Post# of 155052
Extension and eIND does not "remove any scientific value".
It has scientific value and importantly, leronlimab per our previous eIND cases, brings recovery rather quickly, 3 to 5 days. So there won't be much doubt that leronlimab brought about the recovery. And s/c death rate of those receiving leronlimab can still be compared to national stats on death of s/c not receiving leronlimab. Doctors will have reasonable confidence that leronlimab is responsible for recoveries they are seeing. The FDA, if they have not yet approved or given EUA, will be interested in our eIND and extension recoveries for sure. I'm excited about news from the eIND and extension recoveries of s/c, however, Phase III s/c data may be out soon anyway.
It has scientific value and importantly, leronlimab per our previous eIND cases, brings recovery rather quickly, 3 to 5 days. So there won't be much doubt that leronlimab brought about the recovery. And s/c death rate of those receiving leronlimab can still be compared to national stats on death of s/c not receiving leronlimab. Doctors will have reasonable confidence that leronlimab is responsible for recoveries they are seeing. The FDA, if they have not yet approved or given EUA, will be interested in our eIND and extension recoveries for sure. I'm excited about news from the eIND and extension recoveries of s/c, however, Phase III s/c data may be out soon anyway.
(2)
(0)
